Location History:
- Colonial Heights, VA (US) (2003 - 2006)
- Ashland, VA (US) (2010 - 2020)
Company Filing History:
Years Active: 2003-2020
Title: David Anderson: Pioneering Advances in Dantrolene Applications
Introduction
David Anderson, based in Ashland, VA, is a distinguished inventor with an impressive portfolio of 24 patents. His innovative work primarily focuses on enhancing medical treatments, particularly in the field of anesthesiology. His inventions have been instrumental in addressing critical medical needs, benefiting both healthcare professionals and patients alike.
Latest Patents
One of Anderson’s latest contributions is a patent related to treatments using dantrolene. This invention features low-volume, safe-for-injection formulations, which present significant advantages over currently approved and marketed dantrolene used for malignant hyperthermia (MH) during anesthetic crises. The new formulation allows for immediate availability to patients experiencing MH, enabling anesthesiologists to concentrate on managing the patient's physiological status rather than being burdened by time-consuming reconstitution processes. Furthermore, this innovative approach demonstrates substantial benefits in preventing and treating neurological, cognitive, and motor dysfunctions related to altered blood flow, whether caused by surgical procedures involving cardiopulmonary bypass (CPB) or other trauma-induced situations.
Career Highlights
Throughout his career, David Anderson has made remarkable strides in medical innovation. With a total of 24 patents to his name, he has consistently contributed valuable technology to healthcare solutions. His work emphasizes efficiency and patient safety, making a tangible difference in the field of anesthesiology and beyond.
Collaborations
David works at Lyotropic Therapeutics, Inc., where he collaborates with notable colleagues such as Benjamin G Cameransi, Jr. and Vincent M Conklin. Their teamwork reflects a dedication to advancing medical technology and improving health outcomes through innovative research and development.
Conclusion
In conclusion, David Anderson’s contributions to the field of medical treatments, particularly through his patent for dantrolene applications, highlight his commitment to innovation and excellence in healthcare. His work not only improves the efficacy of anesthetic interventions but also sets a precedent for future advancements in the medical field. The collaborative efforts at Lyotropic Therapeutics, Inc. further emphasize the importance of teamwork in driving innovation and enhancing patient care.